Brand medication increases and generics for release in 2019

As an established Medicare Secondary Payer (MSP) compliance services provider, one of our goals is to keep clients, and the property and casualty insurance industry, informed of changes affecting MSP compliance and Workers’ Compensation Medicare Set Asides (WCMSAs).

As part of our best business practices, we continually monitor the RED BOOK® Average Wholesale Price (AWP) changes of the most common medications in WCMSAs as well as generic medications that come to market. This practice assists in identifying price changes that affect WCMSAs.

Read moreBrand medication increases and generics for release in 2019

FDA approves first generic of Advair Diskus® inhaler for asthma and COPD

This content is crossposted from our Optum Insights blog. The U.S. Food and Drug Administration (FDA) has approved the first generic version of Advair Diskus® (fluticasone propionate and salmeterol inhalation powder). Mylan is the first company to obtain FDA approval to market its generic inhaler. Advair Diskus, manufactured by GlaxoSmithKline, received its FDA approval in … Read moreFDA approves first generic of Advair Diskus® inhaler for asthma and COPD